pentobarbital will lower the level or result of fostemsavir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
pentobarbital will decrease the extent or effect of eplerenone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Unidentified.
pentobarbital will minimize the extent or impact of hydrocortisone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.
pentobarbital will raise the amount or impact of clopidogrel by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
Keep track of Intently (one)pentobarbital will lessen the extent or effect of linagliptin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check. Use of alternative treatment options is strongly encouraged when linagliptin will be to be administered which has a CYP3A4 inducer
pentobarbital will reduce the extent or influence of celecoxib by affecting hepatic enzyme CYP2C9/ten metabolism. Slight/Significance Mysterious.
pentobarbital will lessen the extent or result of meloxicam by impacting hepatic enzyme CYP2C9/10 metabolism. Small/Significance Unknown.
pentobarbital and daridorexant both improve sedation. Modify Therapy/Monitor Intently. Coadministration improves chance of CNS melancholy, which may lead to additive impairment of psychomotor general performance and bring about daytime impairment.
Contraindicated (one)pentobarbital will decrease the level or result of dienogest/estradiol valerate by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Women of all ages shouldn't pick estradiol valerate/dienogest as their contraceptive even though applying powerful CYP3A4 inducers resulting from potential reduce in contraceptive efficacy.
펜토바르비탈은 라이 증후군의 두개내의 압력을 줄이기 위해 사용되며, 또한 대뇌 빈혈환자의 뇌 손상을 줄이고, 뇌사를 낮추기 위해 사용된다.
Contraindicated (1)pentobarbital will lessen the level or outcome of lonafarnib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Lonafarnib is really a delicate CYP3A4 substrate. Coadministration with robust or moderate CYP3A4 inducers is contraindicated.
pentobarbital will decrease the extent or influence of fentanyl transdermal by impacting read more hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Closely. Coadministration of fentanyl with CYP3A4 inducers could lead to the lessen in fentanyl plasma concentrations, insufficient efficacy or, probably, development of the withdrawal syndrome within a patient who may have designed physical dependence to fentanyl.
Keep track of Intently (one)pentobarbital will lessen the level or outcome of gefitinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will reduce the level or influence of ramelteon by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Unknown.